USD 29.43
(0.14%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 339.66 Million USD | -1.31% |
2022 | 344.17 Million USD | 86.58% |
2021 | 184.46 Million USD | -18.82% |
2020 | 227.23 Million USD | 16.18% |
2019 | 195.59 Million USD | 8.78% |
2018 | 179.8 Million USD | 8.31% |
2017 | 166 Million USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | -100.0% |
2014 | 24.39 Million USD | 0.0% |
2013 | - USD | -100.0% |
2012 | 13 Million USD | 46.35% |
2011 | 8.88 Million USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 Q2 | 442.25 Million USD | 11.51% |
2023 Q1 | 396.62 Million USD | -11.61% |
2023 Q4 | 373.54 Million USD | 9.98% |
2023 Q3 | 339.66 Million USD | -23.2% |
2023 FY | 339.66 Million USD | -1.31% |
2022 Q1 | 339.63 Million USD | 0.17% |
2022 Q3 | 344.17 Million USD | 1.23% |
2022 Q4 | 448.73 Million USD | 30.38% |
2022 FY | 344.17 Million USD | 86.58% |
2022 Q2 | 339.98 Million USD | 0.1% |
2021 Q2 | 338.17 Million USD | -0.75% |
2021 Q4 | 339.05 Million USD | 0.11% |
2021 Q3 | 338.69 Million USD | 0.15% |
2021 Q1 | 340.72 Million USD | 56.9% |
2021 FY | 184.46 Million USD | -18.82% |
2020 FY | 227.23 Million USD | 16.18% |
2020 Q2 | 214.25 Million USD | 2.11% |
2020 Q3 | 218.84 Million USD | 2.14% |
2020 Q4 | 217.16 Million USD | -0.77% |
2020 Q1 | 209.81 Million USD | 7.27% |
2019 Q3 | 191.44 Million USD | 2.14% |
2019 Q2 | 187.43 Million USD | 2.11% |
2019 Q4 | 195.59 Million USD | 2.17% |
2019 Q1 | 183.55 Million USD | 2.09% |
2019 FY | 195.59 Million USD | 8.78% |
2018 Q3 | 176.18 Million USD | 2.03% |
2018 FY | 179.8 Million USD | 8.31% |
2018 Q1 | 169.28 Million USD | 1.97% |
2018 Q2 | 172.67 Million USD | 2.0% |
2018 Q4 | 179.8 Million USD | 2.06% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 FY | 166 Million USD | 0.0% |
2017 Q4 | 166 Million USD | 1.99% |
2017 Q3 | 162.75 Million USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q3 | - USD | -100.0% |
2015 FY | - USD | -100.0% |
2015 Q1 | 22.01 Million USD | -9.75% |
2015 Q2 | 19.62 Million USD | -10.86% |
2014 Q3 | 22.29 Million USD | 9.83% |
2014 Q2 | 20.29 Million USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 FY | 24.39 Million USD | 0.0% |
2014 Q4 | 24.39 Million USD | 9.41% |
2013 Q1 | 10.02 Million USD | -22.91% |
2013 Q3 | 4.36 Million USD | -39.38% |
2013 Q4 | - USD | -100.0% |
2013 FY | - USD | -100.0% |
2013 Q2 | 7.2 Million USD | -28.12% |
2012 Q2 | 17.08 Million USD | 115.89% |
2012 Q3 | 15.2 Million USD | -10.99% |
2012 Q4 | 13 Million USD | -14.47% |
2012 FY | 13 Million USD | 46.35% |
2012 Q1 | 7.91 Million USD | -10.95% |
2011 Q4 | 8.88 Million USD | 99.28% |
2011 Q3 | 4.45 Million USD | -8.57% |
2011 Q2 | 4.87 Million USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 FY | 8.88 Million USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2008 Q4 | - USD | -100.0% |
2008 Q2 | 4.47 Million USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q3 | 3.12 Million USD | -30.2% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Esperion Therapeutics, Inc. | 501.54 Million USD | 32.276% |
Theratechnologies Inc. | 51.26 Million USD | -562.619% |
Safety Shot Inc | 304.9 Thousand USD | -111299.541% |
Cosmos Health Inc. | 3.03 Million USD | -11090.341% |
Cronos Group Inc. | 1.55 Million USD | -21687.364% |
Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 31.836% |
Kala Pharmaceuticals, Inc. | 34.19 Million USD | -893.463% |
Organogenesis Holdings Inc. | 60.74 Million USD | -459.165% |
Universe Pharmaceuticals INC | - USD | -Infinity% |
ProPhase Labs, Inc. | 10.25 Million USD | -3211.221% |
Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -390319.54% |
Dynavax Technologies Corporation | 252.41 Million USD | -34.564% |
China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -289892.231% |
Alvotech | 1.02 Billion USD | 66.951% |
Sunshine Biopharma, Inc. | 539.03 Thousand USD | -62913.533% |
Alpha Teknova, Inc. | 13.25 Million USD | -2463.316% |
Intra-Cellular Therapies, Inc. | 13.32 Million USD | -2448.889% |
SCYNEXIS, Inc. | 12.15 Million USD | -2693.527% |
Harrow Health, Inc. | 183.17 Million USD | -85.435% |
Biofrontera Inc. | 804 Thousand USD | -42146.891% |
DURECT Corporation | 2.7 Million USD | -12470.873% |
Supernus Pharmaceuticals, Inc. | 33.19 Million USD | -923.211% |
ANI Pharmaceuticals, Inc. | 309.66 Million USD | -9.686% |
OptiNose, Inc. | 611 Thousand USD | -55491.653% |
RedHill Biopharma Ltd. | 455 Thousand USD | -74551.648% |
Aquestive Therapeutics, Inc. | 91.07 Million USD | -272.947% |
Cumberland Pharmaceuticals Inc. | 12.78 Million USD | -2556.924% |
SIGA Technologies, Inc. | 335.99 Thousand USD | -100993.482% |
Lifecore Biomedical, Inc. | 120.51 Million USD | -181.856% |
Shineco, Inc. | 10.01 Million USD | -3290.773% |
Phibro Animal Health Corporation | 458.28 Million USD | 25.884% |
Procaps Group S.A. | 28.41 Million USD | -1095.583% |
TherapeuticsMD, Inc. | 6.53 Million USD | -5100.015% |
Regencell Bioscience Holdings Limited | - USD | -Infinity% |
Viatris Inc. | 16.18 Billion USD | 97.902% |
Sunshine Biopharma, Inc. | 539.03 Thousand USD | -62913.533% |
Rockwell Medical, Inc. | 8.29 Million USD | -3995.804% |
Incannex Healthcare Limited | 210 Thousand USD | -161645.238% |
Aytu BioPharma, Inc. | 10.87 Million USD | -3022.782% |
Tilray Brands, Inc. | 287.93 Million USD | -17.966% |
Collegium Pharmaceutical, Inc. | 489.96 Million USD | 30.675% |
PetIQ, Inc. | 437.82 Million USD | 22.419% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Neurocrine Biosciences, Inc. | 258.3 Million USD | -31.5% |
Journey Medical Corporation | 14.62 Million USD | -2222.972% |
Alimera Sciences, Inc. | 64.48 Million USD | -426.702% |
Petros Pharmaceuticals, Inc. | 6.85 Million USD | -4853.288% |
Assertio Holdings, Inc. | 38.51 Million USD | -781.926% |
Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -251337.941% |
Embecta Corp. | 1.62 Billion USD | 79.103% |
Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -1510596.495% |
Procaps Group, S.A. | 28.41 Million USD | -1095.583% |
PainReform Ltd. | 30 Thousand USD | -1132116.667% |
Avadel Pharmaceuticals plc | 32.75 Million USD | -936.828% |
Hempacco Co., Inc. | 5.93 Million USD | -5626.942% |
Talphera, Inc. | - USD | -Infinity% |
Pacira BioSciences, Inc. | 513.79 Million USD | 33.891% |
Alvotech | 1.02 Billion USD | 66.951% |
Lantheus Holdings, Inc. | 616.12 Million USD | 44.871% |
Kamada Ltd. | 7.43 Million USD | -4466.617% |
Indivior PLC | 235.66 Million USD | -44.129% |
Currenc Group, Inc. | 2.5 Million USD | -13448.804% |
Evoke Pharma, Inc. | 5 Million USD | -6693.3% |
Flora Growth Corp. | 942 Thousand USD | -35957.856% |
Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -1510596.495% |
Evolus, Inc. | 120.35 Million USD | -182.21% |
HUTCHMED (China) Limited | 48.18 Million USD | -604.86% |
Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 42.351% |
Akanda Corp. | 2.49 Million USD | -13502.079% |